Comparison of Methods of Weaning From Nasal CPAP in Preterm Infants: A Randomized Controlled Trial
NCT ID: NCT07009366
Last Updated: 2025-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2024-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Weaning of Nasal Continuous Positive Airway Pressure (CPAP) From Preterm Infants
NCT02126501
Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates
NCT02064712
Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants
NCT01721629
A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation
NCT03292562
Weaning Preterm Neonates From Nasal Continuous Positive Airway Pressure
NCT01093495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sudden weaning of NCPAP
NCPAP was taken "off" entirely when the neonate met the "stability criteria" and remained on oxygen or room air via a headbox or incubator with an aim to stay off NCPAP.
Sudden weaning of NCPAP
NCPAP was taken "off" entirely when the neonate met the "stability criteria" and remained on oxygen or room air via a headbox or incubator with an aim to stay off NCPAP.
Gradual Weaning with increasing the time off NCPAP
The regimen adopted for this method was 1 hour off twice a day on the 1st day, then 2 hours off twice a day on the 2nd day, hence increasing the time off to 6 hours twice a day (or 12 hours per day), i.e., using a smaller period off. At this point, NCPAP was taken off completely.
Gradual weaning with increasing the time off NCPAP
The regimen adopted for this method was 1 hour off twice a day on the 1st day, then 2 hours off twice a day on the 2nd day, hence increasing the time off to 6 hours twice a day (or 12 hours per day), i.e., using a smaller period off. At this point, NCPAP was taken off completely.
Pressure weaning of NCPAP
In this method the pressure was reduced in steps of 1 cm of H2O every 12 to 24 hours until 5 cm of H2O, and then if the child tolerated it well, NCPAP was removed, and the child was shifted to oxygen via incubator or room air according to the situation.
Pressure weaning of NCPAP
In this method the pressure was reduced in steps of 1 cm of H2O every 12 to 24 hours until 5 cm of H2O, and then if the child tolerated it well, NCPAP was removed, and the child was shifted to oxygen via incubator or room air according to the situation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sudden weaning of NCPAP
NCPAP was taken "off" entirely when the neonate met the "stability criteria" and remained on oxygen or room air via a headbox or incubator with an aim to stay off NCPAP.
Gradual weaning with increasing the time off NCPAP
The regimen adopted for this method was 1 hour off twice a day on the 1st day, then 2 hours off twice a day on the 2nd day, hence increasing the time off to 6 hours twice a day (or 12 hours per day), i.e., using a smaller period off. At this point, NCPAP was taken off completely.
Pressure weaning of NCPAP
In this method the pressure was reduced in steps of 1 cm of H2O every 12 to 24 hours until 5 cm of H2O, and then if the child tolerated it well, NCPAP was removed, and the child was shifted to oxygen via incubator or room air according to the situation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any gender
* Low birth weight
* Gestational ages between 28 to below 37 weeks
* Presented with respiratory distress
* Neonates with radiological findings suggestive of respiratory distress, congenital pneumonia/sepsis, or transient tachypnea of the newborn (TTN)
Exclusion Criteria
* Intraventricular hemorrhage grade III or IV or low APGAR scores (\<4 or 5 at 5 minutes)
1 Hour
24 Hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RESnTEC, Institute of Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rabia Asif
Role: PRINCIPAL_INVESTIGATOR
Ziauddin University Karachi
Heena Rais, FCPS
Role: STUDY_DIRECTOR
Ziauddin University Karachi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziauddin University
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DRRABIAZUK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.